| UniProt ID | SYT7_HUMAN | |
|---|---|---|
| UniProt AC | O43581 | |
| Protein Name | Synaptotagmin-7 {ECO:0000305} | |
| Gene Name | SYT7 {ECO:0000312|HGNC:HGNC:11514} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 403 | |
| Subcellular Localization |
Cell membrane Single-pass membrane protein . Cell junction, synapse, presynaptic cell membrane Single-pass membrane protein . Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane Single-pass membrane protein . Lysosome membrane Single |
|
| Protein Description | Ca(2+) sensor involved in Ca(2+)-dependent exocytosis of secretory and synaptic vesicles through Ca(2+) and phospholipid binding to the C2 domain (By similarity). Ca(2+) induces binding of the C2-domains to phospholipid membranes and to assembled SNARE-complexes; both actions contribute to triggering exocytosis (By similarity). SYT7 binds Ca(2+) with high affinity and slow kinetics compared to other synaptotagmins (By similarity). Involved in Ca(2+)-triggered lysosomal exocytosis, a major component of the plasma membrane repair. [PubMed: 11342594 Ca(2+)-regulated delivery of lysosomal membranes to the cell surface is also involved in the phagocytic uptake of particles by macrophages (By similarity Ca(2+)-triggered lysosomal exocytosis also plays a role in bone remodeling by regulating secretory pathways in osteoclasts and osteoblasts (By similarity In case of infection, involved in participates cell invasion by Trypanosoma cruzi via Ca(2+)-triggered lysosomal exocytosis] | |
| Protein Sequence | MYRDPEAASPGAPSRDVLLVSAIITVSLSVTVVLCGLCHWCQRKLGKRYKNSLETVGTPDSGRGRSEKKAIKLPAGGKAVNTAPVPGQTPHDESDRRTEPRSSVSDLVNSLTSEMLMLSPGSEEDEAHEGCSRENLGRIQFSVGYNFQESTLTVKIMKAQELPAKDFSGTSDPFVKIYLLPDKKHKLETKVKRKNLNPHWNETFLFEGFPYEKVVQRILYLQVLDYDRFSRNDPIGEVSIPLNKVDLTQMQTFWKDLKPCSDGSGSRGELLLSLCYNPSANSIIVNIIKARNLKAMDIGGTSDPYVKVWLMYKDKRVEKKKTVTMKRNLNPIFNESFAFDIPTEKLRETTIIITVMDKDKLSRNDVIGKIYLSWKSGPGEVKHWKDMIARPRQPVAQWHQLKA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MYRDPEAAS ------CCCCHHHCC | 24.59 | 23663014 | |
| 9 | Phosphorylation | YRDPEAASPGAPSRD CCCHHHCCCCCCCHH | 30.80 | 23663014 | |
| 49 | Phosphorylation | QRKLGKRYKNSLETV HHHHHHHHHCHHHCC | 20.29 | 27732954 | |
| 50 | Ubiquitination | RKLGKRYKNSLETVG HHHHHHHHCHHHCCC | 44.06 | 32142685 | |
| 52 | Phosphorylation | LGKRYKNSLETVGTP HHHHHHCHHHCCCCC | 24.35 | 22617229 | |
| 55 | Phosphorylation | RYKNSLETVGTPDSG HHHCHHHCCCCCCCC | 29.54 | 25849741 | |
| 58 | Phosphorylation | NSLETVGTPDSGRGR CHHHCCCCCCCCCCC | 21.42 | 30278072 | |
| 58 (in isoform 6) | Phosphorylation | - | 21.42 | 25849741 | |
| 58 (in isoform 5) | Phosphorylation | - | 21.42 | 25849741 | |
| 58 (in isoform 4) | Phosphorylation | - | 21.42 | 25849741 | |
| 58 (in isoform 3) | Phosphorylation | - | 21.42 | 25849741 | |
| 61 (in isoform 6) | Phosphorylation | - | 31.43 | 25849741 | |
| 61 (in isoform 5) | Phosphorylation | - | 31.43 | 25849741 | |
| 61 (in isoform 4) | Phosphorylation | - | 31.43 | 25849741 | |
| 61 (in isoform 3) | Phosphorylation | - | 31.43 | 25849741 | |
| 61 | Phosphorylation | ETVGTPDSGRGRSEK HCCCCCCCCCCCCCC | 31.43 | 25849741 | |
| 82 | Phosphorylation | AGGKAVNTAPVPGQT CCCEEEECCCCCCCC | 26.24 | 23312004 | |
| 89 | Phosphorylation | TAPVPGQTPHDESDR CCCCCCCCCCCCCCC | 28.62 | 28348404 | |
| 94 | Phosphorylation | GQTPHDESDRRTEPR CCCCCCCCCCCCCCC | 42.34 | 28348404 | |
| 98 | Phosphorylation | HDESDRRTEPRSSVS CCCCCCCCCCCCHHH | 51.76 | 28348404 | |
| 102 | Phosphorylation | DRRTEPRSSVSDLVN CCCCCCCCHHHHHHH | 45.89 | 26657352 | |
| 103 | Phosphorylation | RRTEPRSSVSDLVNS CCCCCCCHHHHHHHH | 27.24 | 28348404 | |
| 105 | Phosphorylation | TEPRSSVSDLVNSLT CCCCCHHHHHHHHHH | 27.46 | 28348404 | |
| 112 (in isoform 2) | Phosphorylation | - | 23.59 | 28102081 | |
| 118 (in isoform 2) | Phosphorylation | - | 5.00 | 28102081 | |
| 119 | Phosphorylation | TSEMLMLSPGSEEDE HHHHHCCCCCCHHHH | 17.16 | 27251275 | |
| 122 | Phosphorylation | MLMLSPGSEEDEAHE HHCCCCCCHHHHHHC | 40.99 | 28348404 | |
| 122 (in isoform 2) | Phosphorylation | - | 40.99 | 28102081 | |
| 142 | Phosphorylation | NLGRIQFSVGYNFQE HCCCEEEEEECCCCC | 9.77 | 28270605 | |
| 145 | Phosphorylation | RIQFSVGYNFQESTL CEEEEEECCCCCCEE | 15.62 | 28270605 | |
| 145 (in isoform 4) | Phosphorylation | - | 15.62 | 28842319 | |
| 150 | Phosphorylation | VGYNFQESTLTVKIM EECCCCCCEEEEEEE | 20.24 | 28270605 | |
| 151 (in isoform 4) | Phosphorylation | - | 26.20 | 27135362 | |
| 151 | Phosphorylation | GYNFQESTLTVKIMK ECCCCCCEEEEEEEE | 26.20 | 28270605 | |
| 153 | Phosphorylation | NFQESTLTVKIMKAQ CCCCCEEEEEEEECC | 21.60 | 28270605 | |
| 156 (in isoform 3) | Phosphorylation | - | 2.73 | 28102081 | |
| 156 (in isoform 5) | Phosphorylation | - | 2.73 | 28102081 | |
| 157 (in isoform 4) | Phosphorylation | - | 2.14 | 28842319 | |
| 158 | Acetylation | TLTVKIMKAQELPAK EEEEEEEECCCCCCC | 50.84 | 7409969 | |
| 162 (in isoform 5) | Phosphorylation | - | 3.12 | 28102081 | |
| 162 (in isoform 3) | Phosphorylation | - | 3.12 | 28102081 | |
| 166 (in isoform 3) | Phosphorylation | - | 45.08 | 28102081 | |
| 166 (in isoform 5) | Phosphorylation | - | 45.08 | 28102081 | |
| 176 | Acetylation | GTSDPFVKIYLLPDK CCCCCCEEEEECCCC | 26.47 | 7409979 | |
| 197 | Phosphorylation | KVKRKNLNPHWNETF HCCCCCCCCCCCCCC | 35.47 | 27251275 | |
| 220 (in isoform 3) | Phosphorylation | - | 7.85 | 28842319 | |
| 226 (in isoform 3) | Phosphorylation | - | 12.59 | 27135362 | |
| 232 (in isoform 3) | Phosphorylation | - | 59.20 | 28842319 | |
| 301 | Phosphorylation | KAMDIGGTSDPYVKV CCEECCCCCCHHHEE | 25.41 | 28102081 | |
| 302 | Phosphorylation | AMDIGGTSDPYVKVW CEECCCCCCHHHEEE | 39.60 | 28102081 | |
| 305 | Phosphorylation | IGGTSDPYVKVWLMY CCCCCCHHHEEEEEE | 20.21 | 28102081 | |
| 312 | Phosphorylation | YVKVWLMYKDKRVEK HHEEEEEECCCCCCC | 17.54 | - | |
| 322 | Phosphorylation | KRVEKKKTVTMKRNL CCCCCCCEEEECCCC | 30.04 | 22817900 | |
| 362 | Phosphorylation | VMDKDKLSRNDVIGK EECHHHCCCCCCCEE | 34.48 | 28102081 | |
| 382 | Ubiquitination | KSGPGEVKHWKDMIA CCCCCCCHHHHHHHC | 39.17 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SYT7_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SYT7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SYT7_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HNRPQ_HUMAN | SYNCRIP | physical | 10734137 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-322, AND MASSSPECTROMETRY. | |